Agilent Technologies reported revenue of $1.83 billion [1] for its second quarter of fiscal year 2026 during a virtual conference call.

The results indicate a recovery in growth and operational efficiency for the life sciences and diagnostics giant. This performance allows the company to raise its financial outlook for the remainder of the fiscal year.

CEO Padraig McDonnell said the company delivered an excellent second quarter with stronger-than-expected revenue growth, significant margin expansion, and double-digit EPS growth. The non-GAAP earnings per share for the second quarter reached $1.00 [2].

Executives said the Ignite program drove an 85 basis point expansion in operating margins [4]. This efficiency gain contributed to the company's decision to update its forward-looking projections.

Agilent now forecasts full-year 2026 earnings per share between $6.00 and $6.10 [3]. The call included contributions from CFO Adam S. Elinoff and Simon May, the president of the Life Sciences & Diagnostics Markets Group.

The company's financial trajectory reflects a broader push toward margin optimization. By leveraging internal programs to reduce costs and improve output, Agilent aims to sustain this growth trend through the end of the year.

“We delivered an excellent second quarter with stronger‑than‑expected revenue growth”

The upward revision of EPS guidance suggests that Agilent is successfully transitioning from a period of stabilization to active growth. The 85 basis point margin expansion indicates that the Ignite program is providing a tangible boost to profitability, potentially making the company more resilient to market volatility in the diagnostics sector.